Teladoc Health (TDOC) Scheduled to Post Earnings on Thursday

Teladoc Health (NYSE:TDOC) is scheduled to release its earnings data after the market closes on Thursday, April 25th. Analysts expect Teladoc Health to post earnings of ($0.47) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.05. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The firm had revenue of $660.50 million for the quarter, compared to analysts’ expectations of $670.79 million. During the same period last year, the firm earned ($0.23) EPS. The company’s quarterly revenue was up 3.6% on a year-over-year basis. On average, analysts expect Teladoc Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Teladoc Health Price Performance

NYSE:TDOC opened at $13.14 on Thursday. Teladoc Health has a 52 week low of $13.03 and a 52 week high of $30.41. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $2.22 billion, a PE ratio of -9.80 and a beta of 0.94. The stock’s 50-day moving average price is $15.89 and its 200-day moving average price is $17.98.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Truist Financial decreased their price target on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a research note on Wednesday, March 6th. Piper Sandler dropped their target price on Teladoc Health from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 21st. Barclays lowered their price target on shares of Teladoc Health from $26.00 to $25.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 21st. DA Davidson decreased their price target on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. Finally, Leerink Partnrs restated a “market perform” rating on shares of Teladoc Health in a report on Monday, February 26th. Eight investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $22.23.

Insider Buying and Selling at Teladoc Health

In other news, insider Arnnon Geshuri sold 7,500 shares of the firm’s stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $15.06, for a total value of $112,950.00. Following the completion of the sale, the insider now directly owns 38,470 shares of the company’s stock, valued at $579,358.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, insider Arnnon Geshuri sold 7,500 shares of Teladoc Health stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $15.06, for a total transaction of $112,950.00. Following the completion of the sale, the insider now directly owns 38,470 shares of the company’s stock, valued at approximately $579,358.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Laizer Kornwasser sold 7,882 shares of Teladoc Health stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $151,176.76. Following the sale, the insider now directly owns 57,223 shares of the company’s stock, valued at $1,097,537.14. The disclosure for this sale can be found here. Insiders sold a total of 135,441 shares of company stock worth $2,038,251 over the last ninety days. 1.63% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in Teladoc Health by 11.8% in the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after acquiring an additional 1,855,480 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Teladoc Health by 116.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,593,819 shares of the health services provider’s stock valued at $93,070,000 after acquiring an additional 1,935,496 shares in the last quarter. Renaissance Technologies LLC raised its holdings in Teladoc Health by 36.6% in the 1st quarter. Renaissance Technologies LLC now owns 3,369,500 shares of the health services provider’s stock valued at $87,270,000 after acquiring an additional 902,100 shares in the last quarter. Two Sigma Investments LP raised its holdings in Teladoc Health by 68.6% in the 1st quarter. Two Sigma Investments LP now owns 3,191,291 shares of the health services provider’s stock valued at $82,654,000 after acquiring an additional 1,298,934 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in Teladoc Health by 2.6% in the 1st quarter. Geode Capital Management LLC now owns 2,225,969 shares of the health services provider’s stock valued at $57,653,000 after acquiring an additional 56,421 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.